SCHEMBL6014462

SCHEMBL6014462

CC=C(N)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21023898 0.72
SCHEMBL18635772 0.72
SCHEMBL12759217 0.69
SCHEMBL18756528 0.69
SCHEMBL8099258 0.69
SCHEMBL5590122 0.69
SCHEMBL12227948 0.69
SCHEMBL5590128 0.69
SCHEMBL13381508 0.69
SCHEMBL3603565 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1093563-A None JP disclosed
JP-2108654-A None JP disclosed
CN-102885708-B Composition for external use OTSUKA PHARMA CO LTD 2015-03-18 CN disclosed
US-7078406-B2 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2006-07-18 US disclosed
US-20040248851-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes Life Technologies Corporation 2004-12-09 US disclosed
US-6815445-B2 FOR USE AS FLUORESCENCE DYES AND PROBES Life Technologies Corporation 2004-11-09 US disclosed
EP-1442027-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2004-08-04 EP disclosed
US-20030105111-A1 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-06-05 US disclosed
WO-2003031419-A1 SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-17 WO disclosed
US-4959493-A CENTRAL NERVOUS SYSTEM DISORDERS SUNTORY LIMITED (JP) 1990-09-25 US disclosed
JP-H02108654-A (2R,3S,4S)-ALPHA-(CARBOXYCYCLOPROPYL)GLYCINE SUNTORY LTD 1990-04-20 JP disclosed
JP-H0193563-A CARBOXYCYCLOPROPYLGLYCINE AND PRODUCTION THEREOF SUNTORY LTD 1989-04-12 JP disclosed